The global HIV drugs market was valued at USD 28.6 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 4.7% from 2024 to 2034, reaching an estimated USD 47.5 billion by 2034. The increasing prevalence of HIV infections, notable advancements in research and development (R&D), and the launch of innovative products are the key factors driving this market....